Results 131 to 140 of about 20,277 (256)

Erratum to: Estimation of the Gini coefficient for the lognormal distribution of income using the Lorenz curve. [PDF]

Springerplus, 2016
Darkwah KA, Nortey EN, Lotsi A.
europepmc   +1 more source

Handling mean–variance scaling in intraspecific trait variability and implications for trait–environment analyses

Methods in Ecology and Evolution, EarlyView.
Abstract Trait‐based ecology increasingly relies on measures of intraspecific trait variability to estimate how trait diversity within species varies across species and environmental gradients. Yet variance and related metrics are often interpreted without considering their intrinsic dependence on the mean, as described by the empirical Taylor's power ...
Miguel A. Ortega, Francesco de Bello, José Ramón Obeso, Paola Laiolo   +3 more
wiley   +1 more source

Mitigating policy uncertainty: What financial markets reveal about firm‐level lobbying

American Journal of Political Science, EarlyView.
Abstract Elections can lead to substantial policy changes and, thus, are a significant source of risk. Firms can respond to such policy uncertainty by lobbying, but it is hard to quantify whether they do so and, if so, how much lobbying benefits them. We construct a new dataset and leverage investors’ expectations of variability in stock returns in the
Kristy Buzard, Nathan Canen, Sebastian Saiegh   +2 more
wiley   +1 more source

Multivariate Poisson lognormal distribution for modeling counts from modern biological data: An overview. [PDF]

Comput Struct Biotechnol J
Subedi S, Dang UJ.
europepmc   +1 more source

Grading‐labour cost analysis of AI‐assisted versus human‐only diabetic retinopathy screening in two Danish healthcare settings

Acta Ophthalmologica, EarlyView.
Abstract Purpose Diabetic retinopathy (DR) screening is essential to prevent vision loss, yet rising diabetes prevalence threatens to outpace ophthalmology capacity. Artificial intelligence (AI) systems can triage retinal images to reduce clinician workload, but economic evidence from high‐income, tax‐funded health systems remains limited.
Lars Grønlykke, Sebastian Wiberg, Alex Carter, Peter Heilbo Ratgen, Simon Joel Lowater, Jakob Kristian Holm Andersen, Thiusius Rajeeth Savarimuthu, Jakob Grauslund   +7 more
wiley   +1 more source

Tests of fit for the power function lognormal distribution. [PDF]

PLoS One
Wang C, Zhu H.
europepmc   +1 more source

Application of Multi‐Method Dating for Understanding the Gravettian North of Moravia, Central Europe

Archaeometry, EarlyView.
ABSTRACT This article presents the results of integrating three methods to assess the age of the Upper Palaeolithic site of Pietraszyn 11 (SW Poland), close to the Moravian Gate. Sediment chronology determined using optically stimulated luminescence produced promising, yet ambiguous results (51.0 ± 3.7 to 20.3 ± 0.7 ka).
A. Wiśniewski, B. Bujalska, D. Popović, M. Baca, K. Zarzecka‐Szubińska, A. Lemanik, M. Hein, S. Talamo, P. Moska, H. Fewlass, D. Tokarz, Z. Jary, B. Przybylski, D. Bobak, M. Połtowicz‐Bobak, K. Wertz, A. Nadachowski   +16 more
wiley   +1 more source

No added cost: Emotion recognition in co‐occurring ADHD and ASD

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives Facial emotion recognition (FER) is fundamental for social interaction, yet this ability is often impaired in attention‐deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). While research has documented these difficulties, two key questions remain: Are these deficits specific to recognising emotions or do they ...
Irene Sophia Plank, Kaltrina Krasniqi, Alexandra Pior, Julia Nowak, Christine M. Falter‐Wagner   +4 more
wiley   +1 more source

Blinatumomab for treatment of children with acute lymphoblastic leukaemia in Hong Kong: A cost‐effectiveness analysis

British Journal of Haematology, EarlyView.
Summary To assess the cost‐effectiveness of blinatumomab plus chemotherapy for paediatric patients from Hong Kong public healthcare provider's perspective, a 10‐year Markov model was designed to simulate outcomes in paediatric patients with newly diagnosed standard‐risk B‐cell ALL at: (1) average risk and (2) high risk of relapse.
Mingjun Rui, Yin Ting Cheung, Hui Zhang, Qiran Wei, Yingcheng Wang, Jiaqi Shi, Chi Kong Li, Joyce H. S. You   +7 more
wiley   +1 more source

Hydroxyurea (hydroxycarbamide) use in adults with haemoglobin SC disease: A real‐world study in Quebec

British Journal of Haematology, EarlyView.
Summary Haemoglobin SC (HbSC) disease is the second most prevalent form of sickle cell disease, but evidence for hydroxyurea (hydroxycarbamide; HU) to prevent pain episodes was limited until the prospective identification of variables as outcomes for treatment (PIVOT) trial.
Alice Girard, Laurianne Charette, Mélissa Haouchine, Laurence Bozec, Mohamed Zakaria Bachir Bouyadjera, Mariane Poitras, Vincent‐Thierry Taillefer, Chloé Trudeau, Yves Pastore, Nathalie Letarte, Stéphanie Forté   +10 more
wiley   +1 more source